Fagron NV

Fagron NV is an innovative pharmaceutical compounding company which provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company is dedicated to helping customers from all over the world to better manage their health by supplying tailored medications to meet their individual needs. Fagron has also developed a number of concepts, vehicles, and formulations to assist in the compounding process. Their product range includes raw materials and utensils, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Furthermore, the company offers educational and training programs to both prescribers and pharmacists through their Fagron Academy.

Fagron NV was founded in 1990 and has since grown to become a multinational business with operations across Latin America, North America, Europe, the Middle East and Africa. Previously known as Arseus NV, the company changed its name to Fagron NV in early 2015 to reflect their new focus on pharmaceutical compounding. In 2019 Fagron had a turnover of over 1.2 billion euros with an international workforce of around 4,500 employees. Their expansive network of products and services across multiple markets and regions has enabled them to become an essential partner for many healthcare professionals.

Fagron NV is committed to safety, excellence and innovation in every aspect of their business. Their investments in research and development are a testament to their commitment to quality and their commitment to educating healthcare professionals about the latest in compounding technology. Fagron’s mission is to provide personalized medicine care, improve health outcomes and reduce the cost of healthcare for their customers.